ArticleClinical & translational immunology2020

Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer.

Damien J Zanker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.